CVRX logo

CVRX INC

CVRXNASDAQ
🏆 #4403 by market capEarnings Nov 5 · PostUS Equity
$1.40—
Last available close · quote unavailable
🔔
Track CVRX
Get earnings, price moves & breaking news on Telegram
Track
24h—
7d▲ 1.5%
14d▲ 0.7%
30d▼ 47.2%
ytd▼ 80.4%
1y▼ 87.1%
🏦Market Cap
$37M
Small Cap
📈Revenue Growth (YoY)
12.0%
Healthy
📊Gross Margin
86.9%
High
💵FCF Margin
—
⚖️P/S Ratio
0.6x
Cheap
Otter Score
—
Insufficient data

Trading Snapshot

Day Range
—
52-Week Range
$1.26 – $11.30
Volume (shares)
—
Avg Volume (shares)
—
Shares Outstanding
26.6M
Next Earnings
2026-11-05

Fundamentals Snapshot

Annual Revenue
$57M
Last Q Revenue
$16M
P/E Ratio
—
P/S Ratio
0.6x
EPS (TTM)
$-1.97
Dividend Yield
—
Dilution (1yr)
+16.0%
CVRX logo

CVRX INC

CVRX
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$57M▲ +10.4% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
85.3%▲ +1.9% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$51M▼ −13.8% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$41M▲ +0.6% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
26.2M▲ +16.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$25M▼ −$31M YoY
StockOtter · stockotter.space

About CVRX INC

CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and bringing to market neuromodulation solutions designed for individuals battling cardiovascular diseases. Its principal offering, Barostim, is an advanced neuromodulation device specifically indicated to ameliorate symptoms for patients diagnosed with heart failure characterized by reduced ejection fraction, often referred to as systolic heart failure. The company employs a diverse distribution strategy, leveraging its internal sales force, alongside sales agents and independent distributors, to reach markets across the United States, Germany, the wider European continent, and other global territories. Incorporated in 2000, CVRx, Inc. is headquartered in Minneapolis, Minnesota.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100

Analyst Ratings

ⓘ
Consensus
Buy
13 analysts
Strong Buy3
Buy6
Hold3
Sell1
Strong Sell0
Ratings as of Oct 2026

Latest News & Updates

News unavailable.